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http://www.cardiothoracicsurgery.org/content/9/1/52RESEARCH ARTICLE Open AccessMultimodal analgesia versus traditional opiate
based analgesia after cardiac surgery, a
randomized controlled trial
Sulman Rafiq1*, Daniel Andreas Steinbrüchel1, Michael Jaeger Wanscher2, Lars Willy Andersen2, Albert Navne1,
Nikolaj Bang Lilleoer1 and Peter Skov Olsen1Abstract
Background: To evaluate if an opiate sparing multimodal regimen of dexamethasone, gabapentin, ibuprofen and
paracetamol had better analgesic effect, less side effects and was safe compared to a traditional morphine and
paracetamol regimen after cardiac surgery.
Methods: Open-label, prospective randomized controlled trial. 180 patients undergoing cardiac procedures through
median sternotomy, were included in the period march 2007- August 2009. 151 patients were available for analysis.
Pain was assessed with the 11-numeric rating scale (11-NRS).
Results: Patients in the multimodal group demonstrated significantly lower average pain scores from the day of
surgery throughout the third postoperative day. Extensive nausea and vomiting, was found in no patient in the
multimodal group but in 13 patients in the morphine group, p < 0.001. Postoperative rise in individual creatinine
levels demonstrated a non-significant rise in the multimodal group, 33.0±53.4 vs. 19.9±48.5, p = 0.133. Patients in
the multimodal group suffered less major in-hospital events in crude numbers: myocardial infarction (MI) (1 vs. 2,
p = 0.54), stroke (0 vs. 3, p = 0.075), dialysis (1 vs. 2, p = 0.54), and gastrointestinal (GI) bleeding (0 vs. 1, p = 0.31).
30-day mortality was 1 vs. 2, p = 0.54.
Conclusions: In patients undergoing cardiac surgery, a multimodal regimen offered significantly better analgesia
than a traditional opiate regimen. Nausea and vomiting complaints were significantly reduced. No safety issues were
observed with the multimodal regimen.
Trial registration: Clinicaltrials.gov identifier: NCT01966172
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Pain after cardiac surgery is caused by several factors;
sternotomy, sternal/rib retraction, pericardiotomy, internal
mammarian artery harvesting, saphenous vein harvesting,
surgical manipulation of the parietal pleura, chest tube in-
sertion and other musculoskeletal trauma during surgery.
Traditionally postoperative pain management after car-
diac surgery has been based on opiate analgesics. However,
opiates have some undesirable dose-related side-effects
such as nausea, constipation, vomiting, dizziness, mental* Correspondence: sulman_raf@hotmail.com
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reproduction in any medium, provided the orconfusion and respiratory depression, which substantially
influence patient recovery and may delay discharge after
surgery [1,2]. Furthermore current evidence suggests, that
poorly treated acute postoperative pain not only influences
patient well-being, but also increases the risk for develop-
ment of chronic pain [1,3,4].
In the last two decades, evidence-based multimodal
opiate-sparing analgesia has become increasingly wide-
spread after non-cardiac surgery [1,5]. The rationale for
administering different analgesics is not only the opiate-
sparing effect, but also the accomplishment of a more
effective pain management, through both central and
peripheral anti-nociceptive mechanisms [1,4,6].d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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their effects by peripheral blockage of prostaglandin
synthesis [1]. NSAIDs have demonstrated opiate sparing
effects in randomized trials after cardiac surgery [2,7,8].
But cardiac surgeons and anaesthesiologists have had
safety concerns with NSAIDs regarding renal impair-
ment, bleeding risk and increased risk for cardiovascular
death [2,9].
Gabapentin is a gamma-aminobutyric acid (GABA) ana-
logue, and is mainly utilized for the treatment of epilepsy
and neuropathic pain, but it has in recent years been used
as part of multimodal regimens after non-cardiac surgery
[1,10]. Gabapentin exerts its effects mainly by inhibiting
central neuronal sensation [1,10]. Recent trials have ex-
amined its efficacy after cardiac surgery, but the results
have been divergent [11-13]. Theoretically the addition
of gabapentin to a NSAID should provide synergistic
analgesic and opiate sparing effects, and indeed this
combination has demonstrated some benefits in other
surgical populations [1,10,14].
Dexamethasone is a corticosteroid, and therefore has
anti-inflammatory properties [15,16]. Small doses of dexa-
methasone have in clinical trials demonstrated improved
postoperative patient recovery by especially reducing fa-
tigue, nausea and vomiting complaints [15,16]
The aim of this study was to evaluate a multimodal anal-
gesic regimen consisting of dexamethasone, gabapentin,
ibuprofen and paracetamol against an opiate based regi-
men of morphine and paracetamol. We hypothesized that
the multimodal regimen had a better analgesic effect,
reflected by an improved pain scoring, and a reduction
of side-effects compared to the morphine group. Further-




One hundred and eighty patients undergoing a cardiac
procedure at our institution were randomized on the
day before surgery. Study period was from March 2007
to August 2009. Inclusion criteria were: age > 18, any
cardiac procedure with sternotomy, and able to give
informed consent. Exclusion criteria were; cardiac
surgery without sternotomy, peripheral neuropathy,
neurological disease, psychiatric illness, history of GI
bleeding, chronic pain (i.e. back pain, cancer, arthritis),
serum creatinine >150 μmol/l, hepatic disease with ele-
vated liver enzymes (SGPT and SGOT elevated to 1.5
times maximum normal value), allergic to study medi-
cation, alcohol abuse, abuse of narcotics or medication,
pregnancy, participation in other clinical trials, insufficient
language skills. In addition intensive care unit (ICU)
stay for more than 24 hours was used as a pre-defined
post randomization exclusion criteria, because prolongedICU stay and ventilator treatment would interfere with
study analgesic protocol.
Ethics
The local ethics committee (Danish Research Ethics
Committee) approved the study. All participants gave
written informed consent before inclusion. The study
was conducted in accordance with the Helsinki 2
declaration.
Study design and randomization
Single-center, prospective randomized controlled trial, with
an open-label design. Patients were approached on the
day before surgery. After obtaining informed consent, the
patients were randomized utilizing sequentially numbered
opaque sealed envelopes to one of two groups (ratio 1:1)
by the study co-ordinator.
Clinicaltrials.gov identifier: NCT01966172.
Anaesthetic management
Identical anaesthetic protocol was used in both groups.
Peripheral venous, central venous and urinary catheters
were inserted. Radial artery pressure was monitored. An-
aesthesia was induced with 2-5 mg of midazolam, 10 μg/
kg of fentanyl and 8 mg pancuronium. After intubation
anaesthesia was supplemented with isoflurane 0.4 to
1 %. Fentanyl was during surgery supplemented up to a
total dose of 25 μg/kg. After finalization of extracor-
poral circulation (ECC) propofol infusion was started at
an infusion rate of 100-200 mg/hour. The patients were
subsequently transferred anaesthetized to the intensive
care unit (ICU) for further stabilization and recovery.
When pressure support on the ventilator was reduced
to 10 cm H2O and Positive End Expiratory pressure
(PEEP) was 5-7 cm H2O, 4 mg of ondasteron iv were
administered, the propofol infusion was stopped and
the patients were extubated.
All patients were given a single 240 mg dose of genta-
micin and a 1500 mg dose of cefuroxim intravenously at
initation of surgery for antibiotic prophylaxis. Cefuroxim
1500 mg three times daily was continued untill the morn-
ing of the third postoperative day.
Surgical procedures
There was no selection for a specific type of cardiac sur-
gery. All surgical procedures were performed through
median sternotomy. Patients undergoing CABG surgery
had left internal mammarian artery (LIMA) pedicled
conduits harvested using a LIMA retractor. Saphenous
vein grafts were harvested using a open technique in
90% of cases, and 10% were harvested with endoscope.
Proximal anastomoses were performed using side clamp.
Patients on ECC were heparinised to maintain an acquired
coagulation time (ACT) above 480 s, and this was reversed
Table 1 Overview of administered analgesics
Multimodal Morphin
Extubation •Inj.ketorolac 30 mg iv •Inj morphine 5-25 mg iv
•Inj dexamethasone 8 mg iv •Inj ondasterone 4 mg iv
•Rectal suppositorium
paracetamol 1000 mg
•Inj ondasterone 4 mg iv
•Rectal suppositorium
paracetamol 1000 mg
Day 1 •Tbl Ibuprofen 400 mg x 4 •Tbl Morphine 10 mg x 4
•Tbl Paracetamol 1000 mg x 4•Tbl Gabapentin 300 mg x 2
•Tbl Paracetamol 1000 mg x 4
Day 2 •Tbl Ibuprofen 400 mg x 4 •Tbl Morphine 10 mg x 4
•Tbl Paracetamol 1000 mg x 4•Tbl Gabapentin 300 mg x 2
•TblParacetamol 1000 mg x 4
Day 3 •Tbl Ibuprofen 400 mg x 4 •Tbl Morphine 10 mg x 4
•Tbl Paracetamol 1000 mg x 4•Tbl Gabapentin 300 mg x 2
•TblParacetamol 1000 mg x 4
Day 4 •Tbl Ibuprofen 400 mg x 4 •Tbl Morphine 10 mg x 4
•Tbl Paracetamol 1000 mg x 4•Tbl Gabapentin 300 mg x 2
•TblParacetamol 1000 mg x 4
Administrations are noted by times daily with (x),, x2 equals twice daily and
x4, four times daily. Inj = injection, iv = intravenous, tbl = tablet.
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Blood cardioplegia was used to induce cardiac arrest.
Two chest tubes (28 F) were placed- one mediastinally
and the other in the left hemithorax- both were passed
subxiphoidally. The sternotomy was closed with 8 steel
wires, and the skin incision was closed with intracutane-
ous suturing.
Analgesic protocol (intervention)
Pre-operatively both groups received 0.125 mg triazolam
orally 1 hour before surgery.
Multimodal group: Before extubation, at the time of
ondasteron administration, 30 mg of ketorolac (a NSAID)
and 8 mg of dexamethason were administered intraven-
ously together with 1 g of paracetamol rectally. In the
evening of the operative day, at 10 pm 300 mg of gabapen-
tin, 1 g of paracetamol and 1 g of the laxative magnesium-
oxide were administered. From the first postoperative
day through the fourth postoperative day, patients received
following oral preparations; 300 mg of gabapentin twice
daily, 400 mg of ibuprofen four times daily, 1 g of para-
cetamol four times daily, 40 mg of the proton pump in-
hibitor pantoprazol once daily and 1 g of magnesiumoxide
once daily.
Morphine group: On arrival at ICU 5 mg of morphine iv
were administered, further administrations were allowed
up to a total of 25 mg. At time of ondasteron administra-
tion before extubation, 1 g of paracetamol was adminis-
tered rectally. At 10 pm 1 g of paracetamol and 1 g og
magnesiumoxide were administered. From the first post-
operative day through the third postoperative day, patients
received following oral preparations; 10 mg of morphine
four times daily, 1 g of paracetamol four times daily,
40 mg pantoprazol once daily and 1 g of magnesiumoxide
once daily. On the fourth day oral morphine was reduced
to 5 mg four times daily.
An overview of administered analgesics is presented in
Table 1.
In both groups, if pain was still unacceptable for the
patient, the attending nurse was allowed to administer
morphine either as an injection of 5-10 mg iv or an oral
dose of 10 mg as needed until pain relief. All administered
doses were recorded. Also administration of extra NSAID
(Ibuprofen and ketorolac) was registered.
In both groups supplementary medication for relief of
nausea was 4 mg ondasteron iv up to three times daily,
and/or 10 mg of metoclopramid iv up to three times
daily.
Data collection
From the evening of surgery, after extubation, and then
every evening until the 4th postoperative day, pain inten-
sity was reported by the patient, utilizing the 11-point
numeric rating scale (11-NRS). For clarity this is thenumeric version of the more widespread visual analogue
scale (VAS). The 11-NRS has been validated as a sensitive
tool for assessing and scoring pain in the postoperative
setting [17]. Patients reported, ‘worst pain’ experienced
during the day, ‘least pain’, ‘average pain’ and ‘current pain’
at 8 pm, all on 11-NRS. Pain status was also reported in
the morning before analgesia administration; patients were
asked for current pain in the sternum, and overall physical
pain both on 11-NRS. Furthermore, patients in the even-
ing reported on a questionnaire whether they had experi-
enced any of following symptoms during the last 24 hours:
nausea, constipation, vomiting, difficulty with urination,
dizziness, mental confusion, difficulty concentrating and
fatigue. The answers were recorded as (‘not at all’, ‘rarely’,
‘sometimes’, ‘often’ and ‘all the time’).
With respect to the secondary outcomes, all major in-
hospital events (cardiac,renal,cerebral,thromboembolic,GI,
sternal) were collected. MI was defined as CKMB levels
over 80 Units/l in the immediate postoperative period,
ECG changes and/or breast pain, coronary angiography
was performed to confirm diagnosis. Re-admission to ICU
and the need for inotropic support was recorded. Creatin-
ine levels during hospitalization were recorded. The need
for dialysis was determined by the attending cardiac sur-
geon and anaesthesiologist. Cerebral complications were
recorded as transitory cerebral ischemia (TCI), if symp-
toms lasted less than 24 hours. Symptoms lasting more
than 24 hours were classified as strokes. Incidence of
GI bleeding or any other bleeding were recorded, and
confirmed by gastroscopy.
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1. Evaluation of analgesic effect by 11-NRS scale.Secondary outcomes
2. Additional analgesic consumption.
3. Hospital stay in days.
4. Evaluation of side-effects by daily questionnaire.
5. Renal complications: increase in creatinine, dialysis.
6. Cardiac complications; Myocardial infarction(MI),
postoperative pericardial effusion, heart failure
requiring inotropic support, atrial fibrillation.
7. Other complications: cerebral (stroke, bleeding),
GI(bleeding), blood component requirements and
sternal complications.
8. Death from all causes.
Outcomes 1-4 were recorded and evaluated during
index hospitalization. Outcomes 5-8 were recorded for
30 days after surgery.Sample size
Sample size was calculated, assuming patients on a mor-
phine regimen would have a mean NRS-11 score of 4, and
patients in the multimodal regimen would have a mean of
3, with a power of 80% and significance level of 5%, each
group would have to have 63 patients. Therefor, initially
75 patients were planned in each group, to account forFigure 1 Study flow-chart.dropouts. As the degree of dropouts due to ICU stay over
24 hours exceeded the expected, it was decided to include
90 patients in each group.
The study was primarily powered to test the primary
hypothesis.Statistical analysis
For categorical variables chi-square tests or the Fischer’s
exact test were used as appropriate, and 2-sided signifi-
cance values were evaluated. For continuous variables
analysis was performed with the two sample t-test, after
ensuring normal distribution of data. Data with no nor-
mal distribution were analyzed by Wilcoxon rank sum
test. Continuous variables are presented as mean±stand-
ard deviation (SD) unless otherwise noted. P < 0.05 was
considered statistically significant. All P-values above
0.10 are denoted NS (non-significant) in tables. Data
entry and analysis was performed blinded to group allo-
cation. All statistical analyses were performed using
SPSS statistical software v.19.0 (SPSS inc, Chicago IL).Results
A total of 180 patients were randomized. Twenty one
patients were excluded after surgery due to prolonged
ICU stay over 24 hours for different reasons i.e. re-do
surgery, heart failure etc. (pre-defined exclusion criteria).
Furthermore 6 patients in the morphine group withdrew
informed consent after surgery, because of nausea/vomit-
ing and reluctance to pain scoring. Two patients were






Types of surgery (n)
CABG 44 42 NS
OPCAB 1 3 NS
CABG + valve 8 8 NS
Valve 18 15 NS
Other 6 6 NS
Perfusion data
Perfusion time (min) 83.4±32.5 91.4±37.6 NS
Clamp time (min) 56.6±26.6 62.4±30.8 NS
CABG = coronary artery bypass graft, OPCAB = off pump coronary artery
bypass.
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teria violation- both had pre-operative creatinine above
150 μmol/l - see flow chart (Figure 1). Thus a total of 29
patients were excluded from the study. Hence data from
151 patients was available for analysis.
Demographic data of these patients are presented in
Table 2.
Operative data are presented in Table 3.
NRS-11 pain scoring data are presented in Table 4. It
is noteworthy that patients in the multimodal group, in
all categories, except “worst pain” on day 4, had lower
mean pain scores. Although not all of these differences
reached statistically significance, patients scored signifi-
cantly lower on average pain sensation from day 0 (day
of surgery) throughout to day 3. The least pain experi-
enced during the day was also lower in the multimodal
group from day 1 to day 3.
Supplemental Analgesics use is presented in Table 5. For
each group it is was recorded how many patients used
supplementary analgesics, and what the mean consump-






Age (Mean ± SD) 62 ± 12 64 ± 13 NS
Female (n) 16 15 NS
BMI (Mean ± SD) 27.4 ± 5.1 28.1 ± 4.3 NS
Risk factors/co-morbidity (n(%))
Hypertension 48 47 NS
Hypercholest. 55 58 NS
Diabetes 8 16 0.06(NS)
Peripheral arterial disease 8 6 NS
Previous TCI/stroke 7 6 NS
Severe COPD 5 4 NS
Alcohol (Median (min-max)) 7[0-42] 6[0-42] NS
Cardiac history (n)
MI past (>months) 14 14 NS
MI present (<3 months) 5 4 NS
CCS 2 ± 1 2 ± 1 NS
NYHA class 2 ± 1 2 ± 1 NS
Atrial fibrillation 5 9 NS
LVEF > 50% 33 35 NS
LVEF 30%-50% 36 26 NS
LVEF <30% 8 13 NS
Euroscore (Mean ± SD 5.0 ± 2.9 5.2 ± 3.4 NS
Creatinine (μmol/J) 82.6 ± 17.0 82.7 ± 15.1 NS
BMI = body mass index, TCI = transitory cerebral ischemia, COPD = chronic
obstructive pulmonary disease, MI = myocardial infarction, CCS = canadian
cardiovascular society, NYHA = New york heart association, LVEF = left
ventricular ejection fraction, NS = non-significant.Duration of hospital stay was insignificantly lower
in multimodal vs. morphine patients, 7.4 days±3.3 vs.
8.2 days ±4.6, p = 0.257.
The comprehensive information collected from side-
effect questionnaires demonstrated only minor non sig-
nificant differences between groups, except for nausea
and vomiting. Thirteen patients in the morphine group
had to stop study medication due to nausea and vomiting
in comparison to none in the multimodal group; 13 vs. 0,
p < 0.001. Of these 13 patients 8 stopped day 1, 4 stopped
day 2 and 1 patient stopped at day 3. The six patients
who withdrew informed consent are not included in
these numbers.
One case of involuntary muscular contractions of the
upper extremities was observed in a patient in the multi-
modal group, and gabapentin was stopped, which lead to
normalization in one day.
In-hospital events, transfusion requirements and 30-
day mortality data are presented in Table 6. The patients
in the multimodal group on average had a greater increase
in creatinine postoperatively although this was not sig-
nificant. Maximum postoperative creatinine levels data
presented as median[min-max] were 92 μmol/l [65-314]
in the multimodal group and 90 μmol/1 [33-411] in the
morphine group. Two patients in the morphine group
and 1 patient in multimodal group had to undergo
hemodialysis. It is also to be noted here, that 4 patients in
the multimodal group had their pain regimen cancelled by
their attending surgeon because of concerns of elevated
creatinine levels. Maximum postoperative creatinine in
μmol/l and the day of stopping for these 5 patients
were respectively: 155 on day 2, 257 on day 2, 260 on
day 1 and 314 on day 3. Elevated creatinine levels did
not lead to cancellation of pain regimen in the morphine
group. Further analysis of creatinine data showed, that
25 patients in the multimodal vs. 14 patients in the
morphine group had a increase of more than 30 percent
Table 4 Pain scoring by 11-NRS














Multimodal 4.5±2.4 NS 4.6±2.4 0.057(NS) 4.4±2.7 0.093(NS) 3.6±2.4 NS 3.9±2.5 NS
Morphine 5.0±2.4 5.5±2.4 5.3±2.1 3.9±2.3 3.5±2.2
Least pain
Multimodal 1.5±0.7 NS 1.6±1.0 0.042 1.7±2.4 0.021 1.3±0.8 0.021 1.4±1.0 NS
Morphine 1.7±0.9 2.1±1.2 2.5±1.7 1.8±0.8 1.6±0.8
Average pain
Multimodal 2.6±1.2 0.022 2.7±1.4 0.005 2.5±1.5 0.001 1.9±1.2 0.032 2.1±1.6 NS
Morphine 3.5±2.0 3.6±1.6 3.9±1.7 2.7±1.5 2.7±1.7
Current pain
Multimodal 2.5±1.8 NS 2.5±2.0 NS 2.1±1.9 NS 1.4±0.9 0.038 1.7±1.5 NS
Morphine 2.3±1.6 3.1±2.2 2.6±1.9 2.2±1.7 1.7±1.0
Morning scores
Sternal pain
Multimodal NA NA 2.3±2.4 0.042 1.7±2.0 NS 1.6±1.7 NS
Morphine 3.1±2.5 2.0±1.8 1.6±1.9
Physical pain
Multimodal NA NA 2.0±2.2 NS 1.4±0.9 NS 1.3±1.7 NS
Morphine 2.3±2.4 2.2±1.7 1.6±1.8
For each day pain scores (mean ± SD) between groups are listed. NA = Not Applicable NS = Non Significant.
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creatinine level, p = 0.089.
Discussion
The present study is the first to compare a multimodal regi-
men consisting of dexamethasone, gabapentin, ibuprofen
and paracetamol against a traditional opiate based regimen
(morphine and paracetamol) after cardiac surgery.Table 5 Supplemental analgesics
Multimodal Morphine P-value
Supplementary morphine
Number of patients 36 42 NS
Average consumption in mg
(mean ± SD)
16.0 ± 17.2 21.6 ± 20.7 NS
Supplementary ibuprofen
Number of patients 12 7 NS
Average consumption in mg
(mean ± SD)
667 ± 394 2171 ± 2929 0.091(NS)
Supplementary ketorolac
Number of patients 3 2 NS
Average consumption in mg
(mean)
30 30 NS
Number of patients in each group that received additional analgesics, the
consumption is for the whole study period, and only for those patients
recieving additional analgesics".Our results show that patients in the multimodal group
had significantly lower “average pain” scores from the day
of surgery to the third postoperative day. Furthermore,
additional morphine requirements and hospitalization
demonstrated a non-significant trend towards improved
outcome in the multimodal group.
These findings are in concordance with findings in other
surgical populations, which have shown improved pain
relief with a multimodal approach [1,14,18].
Equally important as pain relief, is the extent of side-
effects from the instituted analgesic regimen. In our study
13 patients in the morphine group experienced nausea
and vomiting, to such a degree, that they had to discon-
tinue their analgesic regimen. It is to be noted, that
morphine does have a dose-related side-effect profile,
and it can be argued that we were not able to titrate
morphine levels down as we would have ie. if we had used
patient administered morphine pumps, when patients
experienced side-effects. But nonetheless none of the
patients in the multimodal group had such extensive
nausea and vomiting symptoms. This was a very convincing
and important finding of this study. Single dose dexametha-
sone has previously been shown to significantly reduce
postoperative nausea and vomiting after cardiac surgery,
and improve quality of recovery [15,16]. Also the use of
NSAIDs instead of opiates after cardiac surgery has been









(μmol/1) (mean ± SD)
117.0 ± 60.9 102.3 ± 50.4 NS
Individual maximum rise
in creatinine (μmol/1)
33.0 ± 53.4 19.9 ± 48.5 NS
Dialysis (n) 1 2 NS
Cardiac complications
Myocardial infarction (n) 1 2 NS
Postoperative pericardial effusion (n) 1 3 NS
Readmitted to ICU for inotropic
support (n)
1 1 NS
Atrial fibrillation 31 34 NS
Cerebral complications
Stroke(n) 0 3 0.075(NS)
TCI (n) 0 1 NS
Involuntary movements (n) 1 0 NS
GI complications
GI bleeding 0 1 NS
Sternal complications
Sternal dehiscence 1 1 NS
Sternal infection 1 2 NS
Transfusion requirements
RBC (units) 1.21 ± 2.03 1.17 ± 2.10 NS
FFP (units) 0.31 ± 0.90 0.26 ± 0.84 NS




Aspirin 63 57 NS
Clopidogrel 2 4 NS
VKA 20 19 NS
Mortality
30 day mortality 1 2 NS
ICU = intensive care unit, RBC = packed red blood cells, FFP = fresh frozen
plasma, PC = platelet concentrates, VKA = vitamin K antagonist.
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and vomiting [2]. However other studies have failed to
demonstrate that NSAIDs reduce nausea and vomiting
after cardiac surgery[7-9]. Gabapentin on its own has in
some studies demonstrated an anti-emetic effect, but these
findings have not been confirmed in patients undergoing
cardiac surgery [3,10,12].
In the present study, renal complications were not sig-
nificantly higher in the multimodal group. But there was
a trend towards patient in the multimodal group having
greater increase in creatinine levels postoperatively. Fur-
thermore, 4 patients in the multimodal group had their
analgesic regimen stopped by the attending surgeonbecause of concerns of rising creatinine levels. It can be
argued that our study lacked power to demonstrate a
significant difference in creatinine level elevations. How-
ever, a review published by Acharya and Dunning in 2010
concluded that “..NSAIDs are not associated with an
increased risk of renal failure after cardiac surgery when
administered at optimal ‘renal’ doses, within early postop-
erative settings, to patients at low-risk of renal dysfunction
in whom NSAIDs are not contraindicated.”[19]. Our re-
sults support this conclusion, but encourage clinicians
to evaluate postoperative creatinine levels regularly when
on a NSAID/gabapentin regimen. This is in fact the
current practice at our institution, where all patients
postoperatively receive a multimodal analgesic regimen
unless it is contraindicated. Creatinine levels are checked
on day 1,2 and 4 postoperatively
Regarding cardiac and cerebral complications, there were
no significant differences between groups. A previous large-
scale multicenter study demonstrated a greater incidence of
cardiovascular events in patients receiving COX-2 inhibi-
tors for 10-14 days [9]. Ketorolac and ibuprofen are the
NSAIDs utilized in our multimodal regimen, these are both
non-selective NSAIDs, and our results do not support the
occurrence of more cardiovascular events in this group.
On the contrary patients in the morphine group in our
study suffered more thromboembolic complications in
crude numbers. A recently published retrospective data-
base study raised concern of NSAIDs as a whole being
associated with increased deaths and recurrent MIs in a
population with previous MI (not a surgical population)
[20]. Interestingly the authors found that ibuprofen usage
below 7 days, was not associated with increased death and
MI [20]. It can be speculated that the lower incidence of
thromboembolic complications in the multimodal group
in our study, was due to the antithrombotic effect of the
NSAIDs [21]. This effect may even be more important
after cardiac surgery, as cardiac sugery has been shown to
induce hypercoagulability and that hypercoagulability is
associated with an increased incidence of thromboembolic
complications and death after cardiac surgery [22,23]. This
is speculative and future studies must elucidate this point.
Limitations
The open label design and lack of placebo usage in this
study are obvious limitations, we have tried to compen-
sate for these by doing data entry and data analysis
blinded to group allocation.
It can be argued that comparison of a whole multimodal
regimen against a morphine regimen, does not pinpoint
the effects of the each drug in the multimodal group, but
we believe this to be a power of this study. Because, as we
demonstrate, the multimodal regimen, does provide better
analgesia with less side-effects after cardiac surgery, and
can be used in a clinical setting as described here.
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In patients undergoing cardiac surgery, a multimodal regi-
men consisting of dexamethasone, gabapentin, ibuprofen
and paracetamol offered better analgesia than a regimen
consisting of morphine and paracetamol. Furthermore,
nausea and vomiting complaints were reduced significantly
in the multimodal group.
Although there was a non-significant increase in indi-
vidual creatinine levels in the multimodal group, no safety
issues regarding dialysis, MI, heart failure, stroke, GI
bleeding and sternal complications and 30-day mortality
were observed.
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